This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1985 Mar;154(3):102-5.

doi: 10.1007/BF02937225.

Gliclazide: the effects on lipids in type II diabetes

M Delargy, M McGovern, A Johnson, G H Tomkin

PMID: 3997441
DOI: 10.1007/BF02937225

Gliclazide: the effects on lipids in type II diabetes

M Delargy et al. Ir J Med Sci. 1985 Mar.

. 1985 Mar;154(3):102-5.

doi: 10.1007/BF02937225.

Authors

M Delargy, M McGovern, A Johnson, G H Tomkin

PMID: 3997441
DOI: 10.1007/BF02937225

No abstract available

PubMed Disclaimer

Similar articles

[Clinical efficacy of glimepiride].
Kaneko T, Sakamoto N. Kaneko T, et al. Nihon Rinsho. 1997 Nov;55 Suppl:152-7. Nihon Rinsho. 1997. PMID: 9434460 Review. Japanese. No abstract available.
[Does hypoglycemic treatment with gliclazide and gliquidone affect platelet function in type II diabetic patients?].
Strojek K, Bresler M, Gumprecht J, Grzeszczak W, Trautsolt W. Strojek K, et al. Pol Arch Med Wewn. 1993 Apr;89(4):315-9. Pol Arch Med Wewn. 1993. PMID: 8351232 Polish.
Clinical evaluation of glimepiride (HOE490) in NIDDM, including a double blind comparative study versus gliclazide.
Tsumura K. Tsumura K. Diabetes Res Clin Pract. 1995 Aug;28 Suppl:S147-9. doi: 10.1016/0168-8227(95)01104-l. Diabetes Res Clin Pract. 1995. PMID: 8529507 Clinical Trial.
Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
Betteridge DJ, Vergès B. Betteridge DJ, et al. Diabetologia. 2005 Dec;48(12):2477-81. doi: 10.1007/s00125-005-0034-1. Epub 2005 Nov 10. Diabetologia. 2005. PMID: 16283239 Clinical Trial.
The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents.
Colagiuri S, Matthews D, Leiter LA, Chan SP, Sesti G, Marre M. Colagiuri S, et al. Diabetes Res Clin Pract. 2018 Sep;143:1-14. doi: 10.1016/j.diabres.2018.05.028. Epub 2018 May 24. Diabetes Res Clin Pract. 2018. PMID: 29802958 Review.

See all similar articles

Cited by

Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.
Palmer KJ, Brogden RN. Palmer KJ, et al. Drugs. 1993 Jul;46(1):92-125. doi: 10.2165/00003495-199346010-00007. Drugs. 1993. PMID: 7691511 Review.

References

1. Clin Chem. 1972 Jun;18(6):499-502 - PubMed
1. Diabetologia. 1982 Jul;23(1):24-7 - PubMed
1. Acta Med Scand. 1979;206(5):351-60 - PubMed
1. Diabetes Care. 1981 Sep-Oct;4(5):561-72 - PubMed
1. Immunochemistry. 1965 Sep;2(3):235-54 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information